Stockreport

Covid Report: Arthritis Drug Tested As Coronavirus Treatment For Critically Ill [Investor's Business Daily]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF On Monday, Sanofi and Regeneron Pharmaceuticals amended a test of arthritis drug Kevzara in coronavirus treatment to focus only on critically ill patients. Severe patien [Read more]